Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Drug Warnings

The Second Circuit upheld the dismissal of a consumer lawsuit alleging Pfizer failed to warn that the drug Lipitor carries a risk of type 2 diabetes, finding that the claims are preempted by federal law and untimely.

MANHATTAN — The Second Circuit upheld the dismissal of a consumer lawsuit alleging Pfizer failed to warn that the drug Lipitor carries a risk of type 2 diabetes, finding that the claims are preempted by federal law and untimely. 

Categories / Appeals, Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...